Atossa Therapeutics
ATOS
$1.56
Share price
1.63%
Change (1 day)
142.97%
Change (1 year)
Categories
EPS for Atossa Therapeutics (ATOS)
EPS in 2023 (TTM): -$0.25
According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.25. In 2022 the company made an earnings per share (EPS) of -$0.21 a decrease over its 2021 EPS that were of -$0.18.
EPS history for Atossa Therapeutics from 2011 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.25 | 19.05% |
| 2022 | -$0.21 | 16.67% |
| 2021 | -$0.18 | -90.86% |
| 2020 | -$1.97 | -3.43% |
| 2019 | -$2.04 | -85.42% |
| 2018 | -$13.99 | -12.45% |
| 2017 | -$15.98 | -42.1% |
| 2016 | -$27.60 | -71.14% |
| 2015 | -$95.64 | -11.44% |
| 2014 | -$108.00 | -11.76% |
| 2013 | -$122.40 | 71.42% |
| 2012 | -$71.40 | 16.51% |
| 2011 | -$61.28 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -5,734.12% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $6.76 | -2,804.00% | 🇺🇸 USA |
 LabCorp LH | $7.52 | -3,108.00% | 🇺🇸 USA |
 NeoGenomics
NEO | -$0.92 | 268.00% | 🇺🇸 USA |
 Enzo Biochem ENZ | -$0.94 | 276.00% | 🇺🇸 USA |